{"id":"lev","safety":{"commonSideEffects":[{"rate":"15-30","effect":"Somnolence"},{"rate":"10-15","effect":"Asthenia/fatigue"},{"rate":"10-15","effect":"Dizziness"},{"rate":"5-10","effect":"Headache"},{"rate":"5-15","effect":"Behavioral/mood changes"},{"rate":"5-10","effect":"Infection"}]},"_chembl":{"chemblId":"CHEMBL150361","moleculeType":"Small molecule","molecularWeight":"170.21"},"_dailymed":{"setId":"6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7","title":"RYTARY (CARBIDOPA AND LEVODOPA) CAPSULE, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Levetiracetam binds to the synaptic vesicle glycoprotein 2A (SV2A) in the brain, which modulates neurotransmitter release and reduces abnormal neuronal firing. This mechanism differs from classical anticonvulsants and helps prevent seizure initiation and spread. The exact downstream effects of SV2A binding that lead to seizure suppression are not fully elucidated but appear to involve modulation of calcium channels and synaptic plasticity.","oneSentence":"LEV (levetiracetam) reduces neuronal excitability and seizure propagation through binding to synaptic vesicle protein SV2A.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:42:30.339Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Partial-onset seizures (adjunctive therapy)"},{"name":"Myoclonic seizures in juvenile myoclonic epilepsy (adjunctive therapy)"},{"name":"Primary generalized tonic-clonic seizures (adjunctive therapy)"}]},"trialDetails":[{"nctId":"NCT06907173","phase":"PHASE3","title":"Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2026-02","conditions":"Status Epilepticus","enrollment":770},{"nctId":"NCT07477431","phase":"PHASE2","title":"Levetiracetam for Persons at Risk for Alzheimer's Disease","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-10-23","conditions":"Hippocampal Hyperactivation, Prodromal Alzheimer Disease","enrollment":40},{"nctId":"NCT02203396","phase":"PHASE2","title":"A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia","status":"COMPLETED","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2014-08","conditions":"Aplastic Anemia","enrollment":40},{"nctId":"NCT07234695","phase":"PHASE3","title":"LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2025-12-22","conditions":"Down Syndrome, Down Syndrome (DS), Down Syndrome (Trisomy 21)","enrollment":120},{"nctId":"NCT02229123","phase":"PHASE2","title":"Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2018-02-27","conditions":"Neonatal Seizures","enrollment":18},{"nctId":"NCT07091175","phase":"PHASE2","title":"Dupilumab Therapy in Nephrotic Syndrome in Children","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-11-27","conditions":"Nephrotic Syndrome in Children, Nephrotic Syndrome Steroid-Dependent","enrollment":66},{"nctId":"NCT05610085","phase":"PHASE2","title":"A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2023-03-24","conditions":"Neonatal Seizure, Neonatal Encephalopathy, Hypoxic-Ischemic Encephalopathy","enrollment":133},{"nctId":"NCT07097025","phase":"","title":"2-Year Study of Vagus Nerve Stimulation for Higher-Grade Treatment-Resistant Depression: Clinical Outcomes and Policy Recommendation","status":"COMPLETED","sponsor":"Dr.Yoav Domany","startDate":"2020-01-01","conditions":"Treatment Resistant Depression (TRD), Depression - Major Depressive Disorder, Bipolar Depression","enrollment":19},{"nctId":"NCT07052136","phase":"NA","title":"Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus","status":"COMPLETED","sponsor":"RESnTEC, Institute of Research","startDate":"2024-11-01","conditions":"Status Epilepticus","enrollment":138},{"nctId":"NCT06773364","phase":"PHASE3","title":"Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-04-30","conditions":"Suspected Stroke","enrollment":2423},{"nctId":"NCT05450978","phase":"","title":"Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2022-07-20","conditions":"Epilepsy, Pregnancy Related","enrollment":60},{"nctId":"NCT04517487","phase":"NA","title":"Vaginal Microbiome Transplantation for Recurrent Bacterial Vaginosis","status":"RECRUITING","sponsor":"Hadassah Medical Organization","startDate":"2020-08-20","conditions":"Bacterial Vaginoses","enrollment":100},{"nctId":"NCT05319639","phase":"PHASE1, PHASE2","title":"Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab","status":"RECRUITING","sponsor":"Fujian Cancer Hospital","startDate":"2023-02-16","conditions":"Gastric Cancer Stage IV","enrollment":51},{"nctId":"NCT06252961","phase":"PHASE2, PHASE3","title":"A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects","status":"RECRUITING","sponsor":"Programme National de Lutte contre l'Onchocercose, Republic of the Congo","startDate":"2024-06-21","conditions":"Loiasis","enrollment":99},{"nctId":"NCT03340064","phase":"PHASE3","title":"A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age","status":"COMPLETED","sponsor":"UCB Japan Co. Ltd.","startDate":"2017-11-30","conditions":"Partial Seizures","enrollment":38},{"nctId":"NCT05772871","phase":"PHASE4","title":"The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children","status":"RECRUITING","sponsor":"Jianhua Zhou","startDate":"2023-04-26","conditions":"Nephrotic Syndrome in Children","enrollment":402},{"nctId":"NCT06404632","phase":"NA","title":"A Group Intervention for Promoting Health-related Habits (LEV-G)","status":"RECRUITING","sponsor":"Region Stockholm","startDate":"2024-04-12","conditions":"Life Style, Health-Related Behavior, Disabilities Mental","enrollment":30},{"nctId":"NCT05889936","phase":"NA","title":"A Transdiagnostic Intervention for Health-related Habits (LEV)","status":"COMPLETED","sponsor":"Region Stockholm","startDate":"2023-01-25","conditions":"Intervention, Life Style, Health-Related Behavior","enrollment":36},{"nctId":"NCT03325439","phase":"PHASE3","title":"A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures","status":"TERMINATED","sponsor":"UCB Biopharma SRL","startDate":"2019-05-07","conditions":"Electroencephalographic Neonatal Seizures","enrollment":9},{"nctId":"NCT00150709","phase":"PHASE3","title":"A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"1998-01-26","conditions":"Epilepsy, Partial","enrollment":223},{"nctId":"NCT04559529","phase":"PHASE2","title":"Pharmacological Modulation of Hippocampal Activity in Psychosis 2","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2020-09-23","conditions":"Schizophrenia; Psychosis","enrollment":62},{"nctId":"NCT06091501","phase":"NA","title":"LIVING - Physical Activity in a Self-management Program Among Persons With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"University of Aarhus","startDate":"2023-10","conditions":"Diabetes Mellitus, Type 2, Randomized Controlled Trial","enrollment":288},{"nctId":"NCT00152503","phase":"PHASE2","title":"Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam","status":"COMPLETED","sponsor":"UCB Pharma SA","startDate":"2005-08-31","conditions":"Epilepsy, Partial","enrollment":59},{"nctId":"NCT03436433","phase":"PHASE2","title":"Seizure Prophylaxis in Patients With Glioma or Brain Metastasis","status":"TERMINATED","sponsor":"Duke University","startDate":"2019-01-31","conditions":"Glioma, Glioma of Brain, Brain Tumor","enrollment":4},{"nctId":"NCT02818738","phase":"PHASE3","title":"Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-09-06","conditions":"First Manifestation of Steroid Sensitive Nephrotic Syndrome","enrollment":86},{"nctId":"NCT02366884","phase":"PHASE2","title":"Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)","status":"UNKNOWN","sponsor":"Dr. Frank Arguello Cancer Clinic","startDate":"2011-07-26","conditions":"Neoplasms","enrollment":250},{"nctId":"NCT04049630","phase":"PHASE2","title":"Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients","status":"COMPLETED","sponsor":"Programme National de Lutte contre l'Onchocercose, Republic of the Congo","startDate":"2021-01-16","conditions":"Onchocerciasis, Ocular, Loiasis","enrollment":255},{"nctId":"NCT05029037","phase":"PHASE3","title":"High-dose Intravenous Vitamin C (HDIVC) as Adjuvant Therapy in Critical Patients With Positive COVID-19. A Pilot Randomized Controlled Dose-comparison Trial.","status":"UNKNOWN","sponsor":"Hugo Galindo","startDate":"2021-09-15","conditions":"Covid19","enrollment":160},{"nctId":"NCT04488458","phase":"NA","title":"Susceptibility Testing of Biofilm to Guide Treatment of Periprosthetic Joint Infections","status":"UNKNOWN","sponsor":"Vastra Gotaland Region","startDate":"2021-08-15","conditions":"Prosthetic Joint Infection, Prosthetic Infection, Hip Prosthesis Infection","enrollment":40},{"nctId":"NCT04277936","phase":"PHASE2","title":"Pharmacologic Modulation of Hippocampal Activity in Psychosis","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2020-05-11","conditions":"Schizophrenia; Psychosis","enrollment":1},{"nctId":"NCT04759196","phase":"PHASE4","title":"Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas","status":"UNKNOWN","sponsor":"Université de Sherbrooke","startDate":"2021-03-01","conditions":"Chronic Subdural Hematoma, Epilepsy; Seizure, Cortical Depression; Cortical Depolarization","enrollment":56},{"nctId":"NCT04680104","phase":"","title":"Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination With 5-Fluorouracil (5FU) /or in FOLFIRI Regimen","status":"COMPLETED","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2015-11-03","conditions":"Gastrointestinal Cancer, CALCIUM LEVOFOLINATO (Ca-lev), SODIUM LEVOFOLINATO (Na-lev)","enrollment":64},{"nctId":"NCT04611373","phase":"PHASE3","title":"Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2020-05-01","conditions":"HCC","enrollment":50},{"nctId":"NCT00615615","phase":"PHASE3","title":"Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"1999-09","conditions":"Epilepsy","enrollment":216},{"nctId":"NCT00150748","phase":"PHASE3","title":"Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy","status":"COMPLETED","sponsor":"UCB Pharma SA","startDate":"2001-11","conditions":"Generalized Epilepsy","enrollment":217},{"nctId":"NCT04425798","phase":"","title":"Connectivity Alterations After Levetiracetam Application","status":"UNKNOWN","sponsor":"Beijing Neurosurgical Institute","startDate":"2022-05-25","conditions":"Glioma, Epilepsy","enrollment":30},{"nctId":"NCT03695094","phase":"PHASE1","title":"A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil","status":"COMPLETED","sponsor":"UCB Biopharma S.P.R.L.","startDate":"2018-09-18","conditions":"Epilepsy","enrollment":31},{"nctId":"NCT04383717","phase":"PHASE3","title":"Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-05-05","conditions":"Respiratory Tract Infections","enrollment":60},{"nctId":"NCT04360122","phase":"PHASE3","title":"Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-05-20","conditions":"Coronavirus Disease (COVID-19)","enrollment":100},{"nctId":"NCT04331470","phase":"PHASE2, PHASE3","title":"Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19","status":"UNKNOWN","sponsor":"Fasa University of Medical Sciences","startDate":"2020-04-04","conditions":"COVID-19","enrollment":30},{"nctId":"NCT01720667","phase":"PHASE1, PHASE2","title":"Efficacy of Intravenous Levetiracetam in Neonatal Seizures","status":"COMPLETED","sponsor":"Richard H. Haas","startDate":"2013-03","conditions":"Neonatal Seizures","enrollment":280},{"nctId":"NCT01137110","phase":"NA","title":"Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After aSAH","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2010-05-01","conditions":"Subarachnoid Hemorrhage","enrollment":84},{"nctId":"NCT03953781","phase":"","title":"Effect of Valproate Versus Levetiracetam Monotherapy on Reproductive Functions in Epileptic Males","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2016-06-01","conditions":"Epilepsy","enrollment":50},{"nctId":"NCT03950518","phase":"PHASE3","title":"Novel Treatment of Advanced Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2019-04-10","conditions":"HCC","enrollment":300},{"nctId":"NCT03940378","phase":"PHASE3","title":"Treatment of Advanced Intrahepatic Cholangiocarcinoma","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2019-02-01","conditions":"ICC","enrollment":152},{"nctId":"NCT03580707","phase":"PHASE2, PHASE3","title":"Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint","status":"COMPLETED","sponsor":"Rosenfeld, William E., M.D.","startDate":"2018-06-01","conditions":"Photosensitive Epilepsy","enrollment":16},{"nctId":"NCT00916149","phase":"NA","title":"Cognitive Effects of Treatment of Interictal Discharges","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2007-01","conditions":"Epilepsy","enrollment":31},{"nctId":"NCT01653262","phase":"PHASE3","title":"Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)","status":"COMPLETED","sponsor":"UCB Pharma SA","startDate":"2012-07","conditions":"Epilepsy","enrollment":29},{"nctId":"NCT00774306","phase":"NA","title":"Antiepileptic Drugs and Vascular Risk Markers","status":"TERMINATED","sponsor":"Thomas Jefferson University","startDate":"2009-04","conditions":"Subarachnoid Hemorrhage","enrollment":52},{"nctId":"NCT02602860","phase":"PHASE1","title":"A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2015-11","conditions":"Healthy Volunteers","enrollment":13},{"nctId":"NCT02726867","phase":"PHASE3","title":"Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus","status":"WITHDRAWN","sponsor":"Mid-Atlantic Epilepsy and Sleep Center, LLC","startDate":"2014-02","conditions":"Epilepsy, Status Epilepticus","enrollment":""},{"nctId":"NCT01375374","phase":"PHASE3","title":"Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide","status":"TERMINATED","sponsor":"UCB Pharma","startDate":"2011-07","conditions":"Epilepsy, Partial","enrollment":11},{"nctId":"NCT01954121","phase":"PHASE3","title":"Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures","status":"COMPLETED","sponsor":"UCB Pharma SA","startDate":"2013-09","conditions":"Epilepsy, Partial Seizures","enrollment":436},{"nctId":"NCT01229735","phase":"PHASE4","title":"Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures","status":"COMPLETED","sponsor":"UCB Korea Co., Ltd.","startDate":"2010-11","conditions":"Epilepsy","enrollment":343},{"nctId":"NCT03218657","phase":"NA","title":"Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole","status":"UNKNOWN","sponsor":"Shengyun Lin","startDate":"2018-01-01","conditions":"Aplastic Anemia","enrollment":248},{"nctId":"NCT01962467","phase":"PHASE1","title":"A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-10-11","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":30},{"nctId":"NCT01383941","phase":"","title":"Asthma Phenotypes in the Inner City","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-08","conditions":"Asthma, Rhinitis","enrollment":717},{"nctId":"NCT00035347","phase":"PHASE4","title":"Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-01","conditions":"Community-Acquired Pneumonia (CAP)","enrollment":219},{"nctId":"NCT02815410","phase":"PHASE2","title":"Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2016-07","conditions":"Glioblastoma Multiforme","enrollment":73},{"nctId":"NCT00406978","phase":"PHASE1, PHASE2","title":"Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients","status":"COMPLETED","sponsor":"Silvio Aime","startDate":"2006-02","conditions":"Multiple Myeloma","enrollment":24},{"nctId":"NCT01506882","phase":"PHASE3","title":"An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy","status":"COMPLETED","sponsor":"UCB Japan Co. Ltd.","startDate":"2011-12","conditions":"Epilepsy, Partial Onset Seizures","enrollment":71},{"nctId":"NCT00291655","phase":"PHASE3","title":"Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903).","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-06","conditions":"Epilepsy","enrollment":130},{"nctId":"NCT02429596","phase":"PHASE4","title":"A Trial of Generic Substitution of Antiepileptic Drugs","status":"UNKNOWN","sponsor":"IRCCS National Neurological Institute \"C. Mondino\" Foundation","startDate":"2012-05","conditions":"Epilepsy","enrollment":200},{"nctId":"NCT00105040","phase":"PHASE2","title":"A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-09","conditions":"Epilepsy, Partial","enrollment":87},{"nctId":"NCT00280696","phase":"PHASE3","title":"A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures","status":"COMPLETED","sponsor":"UCB Japan Co. Ltd.","startDate":"2005-11","conditions":"Epilepsies, Partial","enrollment":352},{"nctId":"NCT00618436","phase":"PHASE4","title":"Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2007-08","conditions":"Traumatic Brain Injury, Subarachnoid Hemorrhage","enrollment":52},{"nctId":"NCT01491113","phase":"PHASE4","title":"Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2011-11","conditions":"Healthy Subjects, Renal Impairments","enrollment":30},{"nctId":"NCT00152373","phase":"PHASE3","title":"Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-07","conditions":"Epilepsy, Partial","enrollment":192},{"nctId":"NCT00160550","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2001-09","conditions":"Generalized Convulsive Epilepsy","enrollment":154},{"nctId":"NCT00003063","phase":"PHASE3","title":"Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer","status":"UNKNOWN","sponsor":"European Institute of Oncology","startDate":"1991-11","conditions":"Colorectal Cancer","enrollment":1050},{"nctId":"NCT00150774","phase":"PHASE3","title":"Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2001-11","conditions":"Generalized Convulsive Epilepsy","enrollment":116},{"nctId":"NCT00705692","phase":"PHASE2","title":"Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2008-03","conditions":"Renal Dialysis","enrollment":40},{"nctId":"NCT00002551","phase":"PHASE3","title":"SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1994-03","conditions":"Colorectal Cancer","enrollment":1917},{"nctId":"NCT00438451","phase":"PHASE4","title":"Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs","status":"COMPLETED","sponsor":"Johannes Gutenberg University Mainz","startDate":"2007-01","conditions":"Focal Epilepsy","enrollment":361},{"nctId":"NCT00152516","phase":"PHASE3","title":"Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-10","conditions":"Epilepsy, Partial","enrollment":255},{"nctId":"NCT01760096","phase":"PHASE2","title":"Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2013-01","conditions":"Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinuria, Hemoglobinuria, Paroxysmal","enrollment":50},{"nctId":"NCT00002593","phase":"PHASE3","title":"S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1994-12","conditions":"Colorectal Cancer","enrollment":1135},{"nctId":"NCT01642979","phase":"PHASE2","title":"Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2012-07","conditions":"Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinuria, Hemoglobinuria, Paroxysmal","enrollment":120},{"nctId":"NCT01618903","phase":"PHASE1","title":"An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2012-05","conditions":"Human Volunteers","enrollment":24},{"nctId":"NCT01579110","phase":"PHASE2","title":"Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2012-04","conditions":"Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune","enrollment":100},{"nctId":"NCT00583947","phase":"PHASE2","title":"A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2008-01","conditions":"Asthma","enrollment":53},{"nctId":"NCT00535392","phase":"PHASE2","title":"Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2007-09","conditions":"Epilepsy","enrollment":33},{"nctId":"NCT01348321","phase":"PHASE2, PHASE3","title":"Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne","status":"COMPLETED","sponsor":"Ahvaz Jundishapur University of Medical Sciences","startDate":"2008-11","conditions":"Acne","enrollment":169},{"nctId":"NCT00425152","phase":"PHASE3","title":"Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer","status":"COMPLETED","sponsor":"NSABP Foundation Inc","startDate":"1989-07","conditions":"Colorectal Cancer","enrollment":2151},{"nctId":"NCT00471744","phase":"PHASE3","title":"HEAD-Study Optimizing the Treatment of Children With BECTS","status":"TERMINATED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2006-06","conditions":"Epilepsy, Rolandic","enrollment":44},{"nctId":"NCT00542802","phase":"PHASE3","title":"Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis","status":"UNKNOWN","sponsor":"Scienze Neurologiche Ospedaliere","startDate":"2007-09","conditions":"Epileptic Seizures, Stroke","enrollment":630},{"nctId":"NCT00659997","phase":"PHASE4","title":"Efficacy Albendazole and Levamisole Against STH on Unguja","status":"COMPLETED","sponsor":"Natural History Museum, United Kingdom","startDate":"2006-06","conditions":"Ascariasis, Trichuriasis","enrollment":20},{"nctId":"NCT00563602","phase":"PHASE4","title":"Treatment for Prevention of Variceal Rebleeding Guided by the Hemodynamic Response","status":"UNKNOWN","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2007-08","conditions":"Portal Hypertension, Complications of Cirrhosis","enrollment":140},{"nctId":"NCT00309530","phase":"PHASE3","title":"Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C","status":"COMPLETED","sponsor":"Austrian Breast & Colorectal Cancer Study Group","startDate":"1990-10","conditions":"Colon Cancer Stage III","enrollment":598}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3172,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"LEV","genericName":"LEV","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"LEV (levetiracetam) reduces neuronal excitability and seizure propagation through binding to synaptic vesicle protein SV2A. Used for Partial-onset seizures (adjunctive therapy), Myoclonic seizures in juvenile myoclonic epilepsy (adjunctive therapy), Primary generalized tonic-clonic seizures (adjunctive therapy).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}